miR-31 modulates dystrophin expression: new implications for Duchenne muscular dystrophy therapy. - RIIP - Réseau International des Instituts Pasteur Access content directly
Journal Articles EMBO Reports Year : 2011

miR-31 modulates dystrophin expression: new implications for Duchenne muscular dystrophy therapy.

Abstract

Duchenne muscular dystrophy (DMD)--which is caused by mutations in the dystrophin gene-is one of the most severe myopathies. Among therapeutic strategies, exon skipping allows the rescue of dystrophin synthesis through the production of a shorter but functional messenger RNA. Here, we report the identification of a microRNA--miR-31--that represses dystrophin expression by targeting its 3' untranslated region. In human DMD myoblasts treated with exon skipping, we demonstrate that miR-31 inhibition increases dystrophin rescue. These results indicate that interfering with miR-31 activity can provide an ameliorating strategy for those DMD therapies that are aimed at efficiently recovering dystrophin synthesis.
Embargoed file
Embargoed file
Visibility date is undetermined
Loading...

Dates and versions

pasteur-00976757 , version 1 (10-04-2014)

Identifiers

Cite

Davide Cacchiarelli, Tania Incitti, Julie Martone, Marcella Cesana, Valentina Cazzella, et al.. miR-31 modulates dystrophin expression: new implications for Duchenne muscular dystrophy therapy.. EMBO Reports, 2011, 12 (2), pp.136-41. ⟨10.1038/embor.2010.208⟩. ⟨pasteur-00976757⟩

Collections

RIIP RIIP_FCB
40 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More